Keyphrases
Liver Transplant Recipients
98%
Liver Transplantation
80%
Hepatocellular Carcinoma
45%
Advanced Hepatocellular Carcinoma
29%
Positron Emission Tomography
21%
Long-term Survival
21%
Chronic Hepatitis C
18%
18F-fluorodeoxyglucose (18F-FDG)
18%
Prostaglandin E1 (PGE1)
18%
Pretransplant
17%
Recurrence-free Survival
16%
Reperfusion
16%
Graft Function
15%
Hepatocellular Carcinoma Recurrence
14%
Xenogeneic
13%
Mycophenolate Mofetil
13%
Ischemia-reperfusion Injury
12%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
12%
Ribavirin
11%
Multivariate Analysis
11%
Tumor Recurrence
11%
Orthotopic Liver Transplantation
11%
Pig Liver
11%
Alprostadil
10%
Calcineurin Inhibitors
10%
Recurrence-free
10%
Tumor
9%
Inducible Nitric Oxide Synthase
9%
Organ Function
9%
Patient Impact
9%
Bridging Therapy
9%
Tumor Necrosis
9%
Renal Disease
9%
Split Liver Transplantation
9%
Aminotransferase
8%
Hepatitis C Virus
8%
C-reactive Protein
8%
Aminoguanidine
8%
Tumor Invasion
8%
Liver Cirrhosis
7%
Early Hepatocellular Carcinoma
7%
Viral Load
7%
Interferon-α (IFN-α)
7%
Milan Criteria
7%
Odds Ratio
7%
Transesophageal Echocardiography
6%
Viremia
6%
Prognostic Impact
6%
Antiviral Treatment
6%
Univariate Analysis
6%
Medicine and Dentistry
Liver Graft
100%
Liver Transplantation
75%
Hepatocellular Carcinoma
64%
Neoplasm
35%
Positron Emission Tomography
29%
Recurrent Disease
28%
Long Term Survival
21%
Hepatitis C
19%
Prostaglandin E1
18%
Fluorodeoxyglucose F 18
16%
Fludeoxyglucose (18F)
14%
Recurrence Free Survival
13%
Allograft
12%
Hepatitis C Virus
11%
Ribavirin
11%
Transaminase
11%
Antiviral Therapy
10%
Common Hepatic Artery
10%
Multivariate Analysis
9%
Ischemia
9%
Calcineurin Inhibitor
9%
Tumor Recurrence
9%
Bilirubin
9%
Tumor Necrosis
9%
Mycophenolate Mofetil
9%
Polyethylene Terephthalate
9%
Survival Rate
9%
Extracorporeal
8%
Milan Criteria
7%
Tumor Invasion
7%
Antivirus Agent
7%
Ex Vivo
6%
Interferon
6%
Living Donors
6%
Fluorine-18
6%
Odds Ratio
6%
Liver Cirrhosis
6%
Decision Making
6%
Diagnosis
6%
Embolization
6%
Fulminant Hepatic Failure
6%
Heart Surgery
6%
Cardiopulmonary Bypass
6%
Liver Support
6%
Viremia
6%
Resistive Index
5%
Maintenance Therapy
5%
C Reactive Protein
5%
Alpha-Fetoprotein
5%
Reperfusion Injury
5%
